Syneos Health, Inc.
SYNH · NASDAQ
6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | |
|---|---|---|---|---|
| Revenue | $1,366 | $1,357 | $1,360 | $1,336 |
| % Growth | 0.7% | -0.2% | 1.8% | – |
| Cost of Goods Sold | $1,071 | $1,089 | $1,042 | $1,018 |
| Gross Profit | $295 | $268 | $318 | $318 |
| % Margin | 21.6% | 19.8% | 23.4% | 23.8% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $183 | $162 | $138 | $130 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$1 | $62 | $62 | $62 |
| Operating Expenses | $242 | $223 | $200 | $192 |
| Operating Income | $42 | $36 | $95 | $118 |
| % Margin | 3.1% | 2.6% | 7% | 8.8% |
| Other Income/Exp. Net | -$42 | -$111 | -$54 | -$1 |
| Pre-Tax Income | $1 | -$75 | $41 | $117 |
| Tax Expense | -$0 | -$3 | -$15 | $30 |
| Net Income | $1 | -$72 | $56 | $87 |
| % Margin | 0.1% | -5.3% | 4.1% | 6.5% |
| EPS | 0.01 | -0.7 | 0.54 | 0.85 |
| % Growth | 101.4% | -229.6% | -36.5% | – |
| EPS Diluted | 0.01 | -0.7 | 0.54 | 0.84 |
| Weighted Avg Shares Out | 104 | 103 | 103 | 103 |
| Weighted Avg Shares Out Dil | 104 | 103 | 103 | 103 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2 | $1 | $1 | $0 |
| Interest Expense | $38 | $26 | $25 | $22 |
| Depreciation & Amortization | $59 | $62 | $57 | $68 |
| EBITDA | $98 | $88 | $123 | $186 |
| % Margin | 7.2% | 6.5% | 9.1% | 13.9% |